
Banaras Hindu
Articles
-
1 month ago |
ova.galencentre.org | Karan Babbar |OP Jindal Global |Mahashweta Chakrabarty |Banaras Hindu
By Karan Babbar, OP Jindal Global University and Mahashweta Chakrabarty, Banaras Hindu UniversitySONIPAT, March 11 – India has made significant progress in addressing menstrual health and hygiene (MHH), with initiatives such as the Menstrual Hygiene Scheme contributing to a substantial increase in access to period products. However, true menstrual equity remains a distant dream for many, particularly in underserved regions.
-
Dec 4, 2024 |
bmcpublichealth.biomedcentral.com | Banaras Hindu
Table 1 shows the weighted percentage distribution of mothers who delivered their last child within the five years preceding the survey, categorized by selected background characteristics. The majority of mothers identified as Hindu (77.1%), and approximately half had completed secondary education. About 40% of mothers belonged to OBC. Additionally, about 88% of mothers were aged 20–34 years at the time of childbirth.
-
Oct 28, 2024 |
bmcpublichealth.biomedcentral.com | Banaras Hindu
The data was drawn from three rounds of the National Family Health Survey (NFHS) conducted in the year 2005-06, 2015-16 and 2019-21. The NFHS is a cross-sectional survey that collects data on a range of demographic, nutritional and public health issues. A total of 124,385, 699,686, and 716,273 women aged 15–49 years participated in NFHS-3, NFHS-4, and NFHS-5, with response rates of 95%, 97%, and 97% respectively. A stratified two stage sample design was used by NFHS [16,17,18].
-
Aug 29, 2024 |
academic.oup.com | Banaras Hindu
While different classes and types of organic molecules have been detected in the interstellar medium (ISM; McGuire 2022), there was no astronomical signature of branched chain molecules (BCMs) and polycyclic aromatic hydrocarbons (PAHs) until the last decade.
-
Jun 20, 2024 |
journals.plos.org | Shyam Sundar |Banaras Hindu |Krishna Pandey |Dinesh Mondal
Citation: Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R, Kumar A, et al. (2024) A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. PLoS Negl Trop Dis 18(6): e0012242.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →